Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Ai-biopharma logo — Artificial Intelligence powered drug discovery Antiviral, HB...

Ai-biopharma

Artificial Intelligence powered drug discovery Antiviral, HBV functional cure, CoV

France France 6 employees Biopharma, Biotechnology +2

General Information

Company Name Ai-biopharma
Location France France +1
Employees 6
Industries Biopharma, Biotechnology, Health Care +1
Social

Get notified when Ai-biopharma moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Ai-biopharma

Ai-biopharma is a Biopharma startup based in France that focuses on artificial intelligence-powered drug discovery, with a particular emphasis on antiviral, HBV functional cure, and CoV-related medications. The company specializes in medicinal chemistry research for preclinical drug candidates, harnessing in-silico solutions such as Chemoinformatics, Molecular Modeling, Docking, Data analysis, and SAR formatting/interpretation. Additionally, Ai-biopharma boasts an Artificial Intelligence platform that accelerates drug design, aiding in the selection of new preclinical candidate drugs. The startup operates in the Biopharma, Biotechnology, Health Care, and Pharmaceutical industries. Despite not having publicly disclosed the date of its last investment or the involved investors, Ai-biopharma has the potential to revolutionize the drug discovery process with its advanced technological approach. As AI continues to reshape various industries, Ai-biopharma's innovative methods could pave the way for groundbreaking developments in the pharmaceutical sphere, making it a compelling prospect for investment.

Taxonomy: Drug Discovery, Medicinal Chemistry, Antiviral, Biopharma, Nucleoside, Nucleotides, Prodrug Targeting, Chemoinformatics, Molecular Modeling, SAR Formatting, QSAR, Preclinical Drug Candidates

No funding data available for Ai-biopharma yet.

Get notified when Ai-biopharma raises funding

Ai-biopharma Alternatives & Competitors

Ai-biopharma vs
Pending AI
Pending AI

Designing Higher-⁠Quality Medicines with Next⁠-⁠Generation Computational Drug Discovery

Ai-biopharma vs
Abion Inc.
Abion Inc. Korea South

ABION, pioneering precision oncology in lung cancer and infectious disease solutions

Series Unknown
23 employees
Health Care, Pharmaceutical
Ai-biopharma vs
OrganOmics
OrganOmics United States

Human Tissues for Human Therapeutics

Non Equity Assistance
2 employees
Biotechnology, Health Care

FAQ About Ai-biopharma

Artificial Intelligence powered drug discovery Antiviral, HBV functional cure, CoV
Ai-biopharma is headquartered in France.
Ai-biopharma operates in the following industries: Biopharma, Biotechnology, Health Care, Pharmaceutical.
Ai-biopharma has approximately 6 employees.
Top alternatives and competitors to Ai-biopharma include Pending AI, Abion Inc., OrganOmics, Envisagenics, Sitka Biopharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ai-biopharma and Pending AI are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Ai-biopharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy